NCT07300852

DSLT in Normal Tension Glaucoma (NTG) Asian Eyes

The Effectiveness of DSLT in Asian Normal Tension Glaucoma Patients

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Ngoc Nguyen Inc. · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is: Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.

Conditions

• Normal Tension Glaucoma (NTG)
• Glaucoma
• Open Angle Glaucoma (OAG)
• Glaucoma, Open Angle

Interventions

Type	Name	Description
DEVICE	Direct Selective Laser Trabeculoplasty (DSLT)	Direct Selective Laser Trabeculoplasty (DSLT) is a non-contact laser procedure that delivers energy to the trabecular meshwork without the need for a gonioscopy lens. The BELKIN Vision Eagle device automatically aligns and applies laser pulses to lower intraocular pressure in subjects with normal tension glaucoma. All participants receive a single DSLT treatment followed by routine post-procedure evaluations including IOP checks, visual field testing, and OCT imaging.

Timeline

• Start date: 2026-01-01
• Primary completion: 2028-01-31
• Completion: 2028-03-31
• First posted: 2025-12-24
• Last updated: 2025-12-24

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study